Research in Behavioral Medicine

Principal Investigators: Conall O’Cleirigh, PhD, Bettina Hoeppner, PhD Funding Source: National Institute of Health (NIH) Project Number: 1R21CA261458-01 Description: People with HIV who smoke lose more life-years to smoking than to HIV. Public health efforts to reduce the prevalence of smoking have under-served this important population, as demonstrated by the prevalence of smoking among persons living with HIV, which is more than twice as high compared to the general population. We propose to develop an integrated smoking cessation treatment that builds on our expertise and the field's successes in leveraging the HIV clinical care setting and smartphone app technology to provide scalable, tailored, sustained smoking cessation support to HIV-positive people who smoke. Potential participants: Currently enrolling participants.

Principal Investigator: Elyse R. Park, PhD, MPH; Jamie Ostroff, PhD Funding Source: National Cancer Institute (NCI) Project Number: 1R01CA214427-01A1 Description: The Smoke Free Support Study 2.0, or SSS2, is designed to examine the effectiveness and implementation of a virtually delivered, evidence-based tobacco treatment, in cancer care for patients in community oncology settings. SSS2 is designed to compare the effectiveness and implementation of an Enhanced Usual Care (EUC; control group) versus a Virtual Intervention Treatment (VIT; intervention group) for tobacco cessation in newly diagnosed cancer patients who smoke. Trial findings will establish the effectiveness and cost of utilizing a virtual strategy to deliver evidence-based tobacco treatment in community oncology settings and provide detailed initial data on implementation processes that will inform subsequent testing of multi-level implementation strategies for broad national dissemination into community cancer care settings. Potential participants: Closed to enrollment

Principal Investigators: Conall O’Cleirigh, PhD, Bettina Hoeppner, PhD Funding Source: National Institute of Health (NIH) Project Number: 1R21CA261458-01 Description: People with HIV who smoke lose more life-years to smoking than to HIV. Public health efforts to reduce the prevalence of smoking have under-served this important population, as demonstrated by the prevalence of smoking among persons living with HIV, which is more than twice as high compared to the general population. We propose to develop an integrated smoking cessation treatment that builds on our expertise and the field's successes in leveraging the HIV clinical care setting and smartphone app technology to provide scalable, tailored, sustained smoking cessation support to HIV-positive people who smoke. Potential participants: Currently enrolling participants.

Principal Investigator: Elyse R. Park, PhD, MPH; Jamie Ostroff, PhD Funding Source: National Cancer Institute (NCI) Project Number: 1R01CA214427-01A1 Description: The Smoke Free Support Study 2.0, or SSS2, is designed to examine the effectiveness and implementation of a virtually delivered, evidence-based tobacco treatment, in cancer care for patients in community oncology settings. SSS2 is designed to compare the effectiveness and implementation of an Enhanced Usual Care (EUC; control group) versus a Virtual Intervention Treatment (VIT; intervention group) for tobacco cessation in newly diagnosed cancer patients who smoke. Trial findings will establish the effectiveness and cost of utilizing a virtual strategy to deliver evidence-based tobacco treatment in community oncology settings and provide detailed initial data on implementation processes that will inform subsequent testing of multi-level implementation strategies for broad national dissemination into community cancer care settings. Potential participants: Closed to enrollment